title: PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.
abstract: OBJECTIVE
  Proprotein convertase subtilisin/kexin type-9 (PCSK9) binds to LDL receptor (LDLR) and targets it for lysosomal degradation in cells. Decreased hepatic clearance of plasma LDL-cholesterol is the primary gauge of PCSK9 activity in humans; however, PCSK9's evolutionary role may extend to other lipoprotein classes and processes. This review highlights studies that are providing novel insights into physiological regulation of PCSK9 transcription and plasma PCSK9 activity.
  
  
  RESULTS
  Recent studies indicate that circulating PCSK9 binds to apolipoprotein B100 on LDL particles, which in turn inhibits PCSK9's ability to bind to cell surface LDLRs. Negative feedback of secreted PCSK9 activity by LDL could serve to increase plasma excursion of triglyceride-rich lipoproteins and monitor lipoprotein remodeling. Recent findings have identified hepatocyte nuclear factor-1α as a key transcriptional regulator that cooperates with sterol regulatory element-binding protein-2 to control PCSK9 expression in hepatocytes in response to nutritional and hormonal inputs, as well as acute inflammation.
  
  
  CONCLUSIONS
  PCSK9 is an established target for cholesterol-lowering therapies. Further study of PCSK9 regulatory mechanisms may identify additional control points for pharmacological inhibition of PCSK9-mediated LDLR degradation. PCSK9 function could reflect ancient roles in the fasting-feeding cycle and in linking lipoprotein metabolism with innate immunity.
authors.affiliation: Department of Pathology and Laboratory Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Lagace
mesh_terms: D001055:Apolipoproteins B / Q000378:metabolism; D005786:Gene Expression Regulation; D022781:Hepatocytes / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics*; D007249:Inflammation / Q000235:genetics* / Q000473:pathology; D008077:Lipoproteins, LDL / Q000235:genetics / Q000378:metabolism; D008247:Lysosomes / Q000378:metabolism / Q000473:pathology; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D059748:Proteolysis; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism*; D012697:Serine Endopeptidases / Q000235:genetics / Q000378:metabolism*
chemical_list: D001055:Apolipoproteins B; C573412:LDLR protein, human; D008077:Lipoproteins, LDL; D011973:Receptors, LDL; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases
references.citation: J Lipid Res. 2008 Jun;49(6):1303-11
references.pmid: 18354138
references.citation: Cell. 2012 Apr 13;149(2):274-93
references.pmid: 22500797
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9820-5
references.pmid: 19443683
references.citation: J Lipid Res. 2008 Feb;49(2):399-409
references.pmid: 17921436
references.citation: J Am Heart Assoc. 2013 Apr 24;2(2):e000028
references.pmid: 23537802
references.citation: J Biol Chem. 2006 Oct 13;281(41):30561-72
references.pmid: 16912035
references.citation: N Engl J Med. 1981 Aug 27;305(9):515-7
references.pmid: 6265781
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1820-5
references.pmid: 18250299
references.citation: Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):160-7
references.pmid: 12588754
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2537-43
references.pmid: 19351729
references.citation: Endocrinology. 2006 Oct;147(10):4985-95
references.pmid: 16794006
references.citation: J Lipid Res. 2010 Jun;51(6):1486-95
references.pmid: 20048381
references.citation: Br J Nutr. 2012 Mar;107(5):705-11
references.pmid: 21787450
references.citation: Nat Genet. 2005 Feb;37(2):161-5
references.pmid: 15654334
references.citation: J Biol Chem. 2009 Oct 16;284(42):28856-64
references.pmid: 19635789
references.citation: Clin Biochem. 2014 May;47(7-8):679-82
references.pmid: 24680982
references.citation: Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1454-9
references.pmid: 15178557
references.citation: Curr Atheroscler Rep. 2013 Mar;15(3):310
references.pmid: 23371064
references.citation: J Biol Chem. 2010 Dec 24;285(52):40965-78
references.pmid: 20937814
references.citation: J Clin Invest. 2001 Jan;107(2):225-34
references.pmid: 11160139
references.citation: N Engl J Med. 2006 Mar 23;354(12):1264-72
references.pmid: 16554528
references.citation: J Biol Chem. 2011 Feb 11;286(6):4257-63
references.pmid: 21147780
references.citation: Nat Genet. 2003 Jun;34(2):154-6
references.pmid: 12730697
references.citation: Pharmacol Rep. 2012;64(4):889-95
references.pmid: 23087140
references.citation: Nat Rev Immunol. 2013 Oct;13(10):709-21
references.pmid: 23995626
references.citation: J Clin Invest. 2006 Nov;116(11):2995-3005
references.pmid: 17080197
references.citation: Nat Struct Mol Biol. 2007 May;14(5):413-9
references.pmid: 17435765
references.citation: J Biol Chem. 2013 Mar 22;288(12):8279-8288
references.pmid: 23400816
references.citation: Hum Mutat. 2009 Apr;30(4):520-9
references.pmid: 19191301
references.citation: N Engl J Med. 2014 May 8;370(19):1809-19
references.pmid: 24678979
references.citation: J Clin Invest. 2000 Feb;105(4):521-32
references.pmid: 10683382
references.citation: J Am Coll Cardiol. 2014 Apr 8;63(13):1278-1288
references.pmid: 24509273
references.citation: Trends Biochem Sci. 2007 Feb;32(2):71-7
references.pmid: 17215125
references.citation: Biochem Biophys Res Commun. 2011 Mar 11;406(2):234-8
references.pmid: 21324305
references.citation: J Biol Chem. 2009 Jul 17;284(29):19211-9
references.pmid: 19416968
references.citation: Mol Cell. 2000 Jul;6(1):77-86
references.pmid: 10949029
references.citation: J Lipid Res. 2014 Jul;55(7):1505-14
references.pmid: 24776539
references.citation: J Biol Chem. 2004 Nov 19;279(47):48865-75
references.pmid: 15358785
references.citation: Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1484-93
references.pmid: 23559630
references.citation: Cell. 1997 May 2;89(3):331-40
references.pmid: 9150132
references.citation: J Biol Chem. 2007 Jul 20;282(29):20799-803
references.pmid: 17537735
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):928-33
references.pmid: 12552133
references.citation: J Clin Invest. 2012 Apr;122(4):1262-70
references.pmid: 22426206
references.citation: J Lipid Res. 2010 Nov;51(11):3359-63
references.pmid: 20716520
references.citation: Biochem Biophys Res Commun. 2008 Sep 19;374(2):341-4
references.pmid: 18638454
references.citation: Curr Opin Lipidol. 2009 Apr;20(2):106-11
references.pmid: 19280766
references.citation: J Biol Chem. 2008 Apr 25;283(17):11374-81
references.pmid: 18272520
references.citation: J Biol Chem. 2013 Jul 26;288(30):21473-81
references.pmid: 23775089
references.citation: J Lipid Res. 2013 Feb;54(2):561-6
references.pmid: 23300213
references.citation: Nature. 1997 Aug 14;388(6643):629-30
references.pmid: 9262394
references.citation: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3441-6
references.pmid: 20133650
references.citation: J Clin Invest. 2002 May;109(9):1125-31
references.pmid: 11994399
references.citation: Nutr Metab (Lond). 2012 Mar 29;9(1):25
references.pmid: 22458435
references.citation: Circulation. 2013 Jun 18;127(24):2403-13
references.pmid: 23690465
references.citation: Arterioscler Thromb Vasc Biol. 2012 Jul;32(7):1585-95
references.pmid: 22580899
references.citation: J Biol Chem. 2007 Jun 22;282(25):18602-18612
references.pmid: 17452316
references.citation: Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2666-72
references.pmid: 20884874
references.citation: J Biol Chem. 2009 Oct 16;284(42):28885-95
references.pmid: 19687008
references.citation: Drug Des Devel Ther. 2013 Oct 04;7:1135-48
references.pmid: 24115837
references.citation: J Am Coll Cardiol. 2014 Jun 17;63(23):2531-2540
references.pmid: 24691094
references.citation: Trends Endocrinol Metab. 2012 Apr;23(4):169-78
references.pmid: 22406271
references.citation: Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1333-9
references.pmid: 20448210
references.citation: EMBO Rep. 2011 Dec 01;12(12):1300-5
references.pmid: 22081141
references.citation: Eur Heart J. 2014 Sep 1;35(33):2249-59
references.pmid: 24598985
references.citation: Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13045-50
references.pmid: 18753623